natgillin/translations-raw huggingface dataset:
Nadomeščanje celic je zdaj edini pristop, ki pri diabetesu tipa 1 omogoča popolno neodvisnost od inzulina.
Cell replacement is currently the only approach that leads to complete insulin independence in type 1 diabetes.
Razvoj intervencijskih študij v otroštvu z namenom preprečevanja/zdravljenja diabetesa tipa 1 je glavna prednostna naloga raziskav diabetesa tipa 1.
Development of interventional trials in childhood, with the aim to prevent/cure type 1 diabetes, is a top priority of research in the setting of type 1 diabetes.
Priloga I, del Teme, oddelek 1 – Zdravje, pododdelek Dejavnosti, drugi podnaslov Translacijske raziskave, ki služijo človekovemu zdravju, podnaslov 4, točka 3 a (novo)
Annex I, 'Themes', section 1 ('Health'), subsection 'Activities', second heading ('Translating research for human health'), subheading 4, point 3 a (new)
· Revmatične bolezni: poudarek bo na etiologiji, zgodnjem diagnosticiranju in bioloških označevalcih za revmatične bolezni in zdravljenju, s posebnim poudarkom na vnetnih revmatičnih boleznih.
Rheumatic diseases: the focus will be on aetiology, early diagnosis and biological markers for rheumatic diseases and treatment, with particular emphasis on inflammatory rheumatic diseases.
Približno tretjina evropskega prebivalstva (okrog 100 milijonov ljudi) enkrat v življenju trpi zaradi revmatične bolezni.
Approximately one third of Europe's population (around 100 million people) suffer from rheumatic diseases at some point in their lives.
Za boljše razumevanje vzroka za takšne bolezni in pridobitev novih in boljših zdravil je nujno potrebno pospešiti raziskovanje in zagotoviti podporo za čezmejno sodelovanje.
There is an urgent need to step up research and provide support for cross-border cooperation with a view to gaining a better understanding of the cause of such diseases and finding new and better remedies.
Pisna izjava št. 389, ki jo je Evropski parlament sprejel 13. oktobra 2005, namenja pozornost pomembnosti raziskav revmatičnih bolezni.
Written Declaration No 389 adopted by the EP on 13 October 2005 drew attention to the importance of research into rheumatic diseases.
Priloga I, del Teme, oddelek 1 ‑ Zdravje, pododdelek Dejavnosti, naslov 2 – Translacijske raziskave, ki služijo človekovemu zdravju, podnaslov 4, zaporedna točka 5
Annex I, part ‘Themes’, section 1 (‘Health’), subsection ‘Activities’, heading 2 ‘Translating research for human health’, subheading 4, bullet 5
Druge kronične bolezni: poudarek bo na nesmrtonosnih boleznih z močnim učinkom na kakovost življenja v starosti, kot so slabšanje funkcionalnih in senzoričnih sposobnosti ter druge kronične bolezni (npr. revmatične bolezni).
Other chronic diseases: the focus will be on non-lethal diseases with a high impact on the quality of life at old age such as functional and sensory impairment and other chronic diseases (e.g. rheumatoid diseases).
Druge kronične bolezni: poudarek bo na nesmrtonosnih boleznih z močnim učinkom na kakovost življenja v starosti, kot so slabšanje funkcionalnih in senzoričnih sposobnosti ter druge kronične , zlasti vnetne bolezni ( npr. revmatične bolezni , kot so revmatični artritis, osteoporoza, demenca in nevrodegenerativne bolezni ).
Other chronic diseases: the focus will be on non-lethal diseases with a high impact on the quality of life at old age such as functional and sensory impairment and other chronic diseases, in particular, inflammatory diseases (e.g. rheumatoid diseases, such as rheumatoid arthritis, osteoporosis, dementia and neurodegenerative diseases ).
Evropa vstopa v obdobje pospešenega staranja prebivalstva.
Europe is entering into a period of accelerating population ageing.
Ker vedno več ljudi živi dlje, se bo število ljudi, ki obolevajo za starostnimi boleznimi, vključno z alzheimerjevo boleznijo, še naprej večalo, po ocenah pa ima zdaj skoraj polovica vseh ljudi, starih 85 let ali več, eno od oblik demence.
As more and more people live longer, the number of people affected by diseases of aging, including Alzheimer Disease (AD), will continue to grow and at the moment is estimated that nearly half of all people age 85 and older have some form of dementia.
Glede na starajoče se prebivalstvo obseg alzheimerjeve bolezni kot evropske zdravstvene težave enakomerno narašča.
Given our aging population, the magnitude of AD as a European health problem is steadily increasing.
Zato je ta bolezen nujna prednostna naloga raziskav.
This makes the disease an urgent research priority.
Intervencije, ki bi lahko preložile pojav alzheimerjeve bolezni in drugih oblik demence, bi imele velik pozitiven vpliv na javno zdravje, ker bi občutno zmanjšale število ljudi, obolelih za to boleznijo.
Interventions that could delay the onset of AD and other forms of dementia would have an enormous positive public health impact because they would greatly reduce the number of people with the disease.
To pa bi zmanjšalo socialne, osebne in finančne stroške, povezane z nego teh ljudi.
This in turn would reduce the social, personal and financial costs associated with caring for them.
Priloga I, del Teme, oddelek 1 ‑ Zdravje, pododdelek Dejavnosti, naslov 2 – Translacijske raziskave, ki služijo človekovemu zdravju, podnaslov 4, zaporedna točka 5 a (novo)
Annex I, part ‘Themes’, section 1 (‘Health’), subsection ‘Activities’, heading 2 ‘Translating research for human health’, subheading 4, bullet 5 a (new)
Druge bolezni: bolezni dihal, zapostavljene bolezni in študije, ki temeljijo na prebivalstvu, za raziskovanje nastajajočih dejavnikov tveganja.
Other diseases: respiratory diseases, neglected diseases and population-based studies to investigate emerging risk factors.
Priloga I, del Teme, oddelek 1 ‑ Zdravje, pododdelek Dejavnosti, naslov 2 – Translacijske raziskave, ki služijo človekovemu zdravju, podnaslov 4, zaporedna točka 5 b (novo)
Annex I, part ‘Themes’, section 1 (‘Health’), subsection ‘Activities’, heading 2 ‘Translating research for human health’, subheading 4, bullet 5 b (new)
Raziskave obnavljanja tkiv: poudarek bo na raziskavah obnavljanja tkiv, kot je obnavljanje kožnega in srčnega tkiva, s ciljem razumevanja mehanizmov, na katerih temeljijo osnovni procesi obnavljanja, ter ugotavljanje inovativnih pristopov za gensko in celično terapijo.
Research on tissue regeneration: the focus will be on research into tissue regeneration, such as skin and heart tissue regeneration, with the aim of understanding the mechanisms underlying regenerative processes and identifying innovative approaches to gene and cell therapies.
V preteklih letih so se nakopičili dokazi poskusov o (resda omejenem) obnavljanju izvornih celic in tkiv v tkivih, za katera je prej veljalo, da te lastnosti nimajo, na primer možgani in srce.
Experimental evidence has accumulated in recent years showing the occurrence of stem cells and tissue regeneration (though limited) in tissues that were previously thought to be lacking this property, such as brain and heart.
Zelo pomembno bo pospešiti raziskave v tej smeri, da se ohrani prednost, ki jo zdaj ima Evropa pred konkurenčnimi državami.
It will be of paramount importance to fuel research in this direction, to maintain an edge that Europe currently has over competing countries.
Ko bo doseženo molekularno razumevanje obnavljanja tkiv pri sesalcih, bodo kmalu vzpostavljeni novi protokoli celične terapije za splošne bolezni, ki so še vedno povezane z visoko stopnjo umrljivosti in obolevnosti ter posledično z visokimi socialnimi in gospodarskimi stroški.
Reaching a molecular understanding of tissue regeneration in mammals will soon lead to new cellular therapy protocols for common diseases, still associated with high mortality and morbidity and consequent high social and economic costs.
Razen tega bodo raziskave na tem področju spodbudile razvoj novih biomaterialov, ki so prav tako bistveno področje biomedicinskih raziskav.
Moreover research in this area will stimulate the development of new bio-materials that also represent a crucial bio-medical research area.
Priloga I, del Teme, oddelek 1 – Zdravje, pododdelek Dejavnosti, tretji naslov Optimalizacija zdravstvenega varstva evropskih državljanov, alinea 1
Annex I, 'Themes', section 1 ('Health'), subsection 'Activities', third heading ('Optimising the delivery of health care to European citizens'), indent 1
– Boljše spodbujanje zdravja in preprečevanje bolezni: zagotovitev dokazov za najboljše ukrepe na področju javnega zdravja v smislu življenjskega sloga in intervencij na različnih ravneh in v različnih kontekstih.
- Enhanced health promotion and disease prevention: to provide evidence for the best public health measures in terms of life styles and interventions at different levels and in different contexts.
Poudarek bo na širših determinantah zdravja in na njihovem vzajemnem delovanju tako na individualni ravni kot tudi na ravni Skupnosti (npr. prehrana, stres, tobak in druge snovi, fizična aktivnost, kulturno ozadje, socialno-ekonomski in okoljski dejavniki).
Focus will be on the wider determinants of health and how they interact at both the individual and community level (e.g. diet, stress, tobacco and other substances, physical activity, cultural context, socio-economic and environmental factors).
Obravnavano bo zlasti duševno zdravje z vidika njegovega vseživljenjskega ohranjanja.
In particular, mental health will be addressed in a life-course perspective.
Poudarek bo na širših determinantah zdravja in na njihovem vzajemnem delovanju tako na individualni ravni kot tudi na ravni Skupnosti (npr. prehrana, stres, tobak in druge snovi, fizična aktivnost, kakovost življenja, kulturno ozadje, socialno-ekonomski, prehrambeni in okoljski dejavniki).
Focus will be on the wider determinants of health and how they interact at both the individual and community level (e.g. diet, stress, tobacco and other substances, physical activity, the quality of life, cultural context, socio-economic , nutritional and environmental factors).
Dejavniki, kot so kakovost življenja ali prehrambene navade posameznikov in skupnosti, odločilno vplivajo na človekovo zdravje in skupaj z drugim dejavniki nanj delujejo pozitivno ali negativno.
Factors such as the quality of life or nutritional habits of individuals and communities have a determining effect on human health and interact in a positive or negative way with other factors.
Zato je bistveno, da se upoštevajo v raziskavah, povezanih z zdravjem.
It is therefore essential for them to be taken into account in health-related research.
Priloga I, del Teme, oddelek 1 ‑ Zdravje, pododdelek Dejavnosti, naslov 3 – Optimizacija zdravstvenega varstva evropskih državljanov, alinea 2
Annex I, part 'Themes', section 1 ('Health'), subsection 'Activities', heading 3 ('Optimising the delivery of health care to European citizens'), indent 2
– Prenos kliničnih raziskav v klinično prakso vključno z boljšo uporabo zdravil ter ustrezno uporabo vedenjskih in organizacijskih intervencij ter terapij in tehnologij zdravljenja.
- Translating clinical research into clinical practice including better use of medicines, and appropriate use of behavioural and organisational interventions and health therapies and technologies.
Posebna pozornost bo namenjena varnosti pacientov: ugotavljanje najboljše klinične prakse; razumevanje kliničnega odločanja v okviru osnovne in specializirane oskrbe; ter pospeševanje uporabe z dokazi podprte medicine in dajanja pooblastil pacientom.
Special attention will be given to patient safety: to identify the best clinical practice; to understand decision making in clinical settings in primary and specialised care; and to foster applications of evidence-based medicine and patient empowerment.
Poudarek bo na primerjavi strategij; proučevanju rezultatov različnih intervencij, vključno z zdravili, ob upoštevanju dokazov farmakovigilance, posebnih značilnosti pacienta (npr. genska odpornost, starost, spol in privrženost načelom) ter stroškovnih ugodnosti.
Focus will be on the benchmarking of strategies; investigating outcomes of different interventions including medicines, taking into consideration pharmacovigilance evidence, specificities of the patient (e.g. genetic susceptibility, age, gender and adherence) and cost benefits.
– Prenos rezultatov kliničnih raziskav v klinično prakso vključno z boljšo uporabo zdravil (npr. za preprečevanje razvoja odpornosti na antibiotike), ter ustrezno uporabo vedenjskih in organizacijskih intervencij ter intervencij v sisteme javnega zdravstva ter terapij in tehnologij zdravljenja.
- Translating the results of clinical research into clinical practice including better use of medicines (e.g. with a view to avoiding the development of antibiotic resistance) , and appropriate use of behavioural , organisational and public health system interventions and health therapies and technologies.
Posebna pozornost bo namenjena varnosti pacientov , vključno s stranskimi učinki zdravil; ugotavljanje najboljše klinične prakse; razumevanje kliničnega odločanja v okviru osnovne in specializirane oskrbe; ter pospeševanje uporabe z dokazi podprte medicine in dajanja pooblastil pacientom , s čimer se okrepi osebna in socialna neodvisnost pacientov.
Special attention will be given to patient safety , including the side-effects of medicines ; to identify the best clinical practice; to understand decision making in clinical settings in primary and specialised care; and to foster applications of evidence-based medicine and patient empowerment with a view to enhancing patients' personal and social autonomy .
Poudarek bo na primerjavi strategij; proučevanju rezultatov različnih intervencij, vključno z zdravili in novimi zdravstvenimi tehnologijami , ob upoštevanju dokazov farmakovigilance, posebnih značilnosti pacienta (npr. genska odpornost, starost, spol in privrženost načelom) ter stroškovnih ugodnosti v zvezi z zdravjem, kakovostjo življenja in dobro prakso .
Focus will be on the benchmarking of strategies; investigating outcomes of different interventions including medicines and new health technologies , taking into consideration pharmacovigilance evidence, specificities of the patient (e.g. genetic susceptibility, age, gender and adherence) and cost benefits in terms of health, quality of life and good practice .
Priloga I, del Teme, oddelek 1 ‑ Zdravje, pododdelek Dejavnosti, naslov 3 – Optimizacija zdravstvenega varstva evropskih državljanov, alinea 3
Annex I, part ‘Themes’, section 1 (‘Health’), subsection ‘Activities’, heading 3 ‘Optimising the delivery of health care to European citizens’, indent 3
– Kakovost, solidarnost in trajnost zdravstvenih sistemov; državam zagotoviti osnovo za prilagajanje njihovih zdravstvenih sistemov glede na izkušnje drugih ob upoštevanju pomembnosti nacionalnega ozadja in značilnosti prebivalstva (staranje, mobilnost, migracije, izobraževanje, socialno-ekonomski položaj, spreminjajoč se svet dela itd.).
– Quality, solidarity and sustainability of health systems; to provide a basis for countries to adapt their health systems in the light of experience of others, taking into account the importance of national contexts and population characteristics (ageing, mobility, migration, education, socioeconomic status and the changing world of work etc).
Poudarek bo na organizacijskih, finančnih in ureditvenih vidikih zdravstvenih sistemov, njihovem izvajanju in rezultatih v smislu uspešnosti, učinkovitosti in enakosti.
Focus will be on organisational, financial and regulatory aspects of health systems, their implementation and their outcomes in terms of effectiveness, efficiency and equity.
Posebna pozornost bo namenjena vprašanju naložb in človeškim virom.
Special attention will be paid to investment issues and human resources.
Posebna pozornost bo namenjena vprašanju naložb in človeškim virom ter dostopu do zdravstvenega varstva za prikrajšane skupine, vključno z invalidnimi osebami.
Special attention will be paid to investment issues and human resources and access to health care for disadvantaged people, including disabled persons.
Preučiti je treba raziskave o tem, kako je zdravstveno varstvo dostopno prikrajšanim skupinam.
Research in respect to how health care reaches disadvantaged groups needs to be investigated.
Priloga I, del Teme, oddelek 1 – Zdravje, pododdelek Dejavnosti, tretji naslov Optimalizacija zdravstvenega varstva evropskih državljanov , alinea 3a (novo)
Annex I, 'Themes', section 1 ('Health'), subsection 'Activities', third heading ('Optimising the delivery of health care to European citizens'), indent 3 a (new)
– Ustrezna uporaba novih tehnologij in terapij.
- Appropriate use of new technologies and therapies.
Dolgoročna varnost in spremljanje obsežne uporabe novih medicinskih tehnologij (vključno z opremo) ter naprednih terapij, ki še zlasti zagotavljajo visoko raven varovanja javnega zdravja.
Long-term safety and monitoring of the large-scale use of new medical technologies (including equipment), and advanced therapies that ensure, in particular, a high level of public health protection.
V skladu z okvirnim programom mora posebni program zajemati ustrezno uporabo novih tehnologij in terapij.
In line with the framework programme, the specific programme should also cover the appropriate use of new technologies and therapies.
Priloga I, del Teme, oddelek 2 ‑ Prehrana, kmetijstvo in biotehnologija, pododdelek Pristop, odstavek 2
Annex I, part "Themes", section 2 ("Food, Agriculture and Biotechnology"), subsection "Approach", paragraph 2
Agroživilska industrija, pri kateri 90 % predstavljajo MSP, bo še zlasti uživala ugodnosti mnogih raziskovalnih dejavnosti, vključno z usmerjenim razširjanjem in dejavnostmi za prenos tehnologije, predvsem v zvezi z vključevanjem in prevzemanjem naprednih, ekološko učinkovitih tehnologij, metodologij in postopkov ter razvojem standardov.
Agro-food industries, of which 90% are SMEs, will particularly benefit from many research activities, including targeted dissemination and technology transfer activities, in particular as regards the integration and uptake of advanced eco-efficient technologies, methodologies and processes and the development of standards.
Pričakovati je, da bodo visokotehnološka, na novo ustanovljena podjetja na področju bio-, nano- ter informacijskih in komunikacijskih tehnologij (IKT) pomembno prispevala na področju žlahtnjenja rastlin, izboljšanih pridelkov in varstva rastlin, naprednih tehnologij za odkrivanje in spremljanje za zagotovitev varne in kakovostne hrane ter novih industrijskih bioprocesov.
High-tech start-ups from the bio-, nano- and ICT are expected to provide important contributions to the areas of plant breeding, improved crops and plant protection, advanced detection and monitoring technologies for ensuring food safety and quality, and new industrial bioprocesses.
Agroživilska industrija, pri kateri 90 % predstavljajo MSP, bo še zlasti uživala ugodnosti mnogih raziskovalnih dejavnosti, vključno z usmerjenim razširjanjem in dejavnostmi za prenos tehnologije, predvsem v zvezi z vključevanjem in prevzemanjem naprednih, ekološko učinkovitih tehnologij, metodologij in postopkov ter razvojem standardov , kar bo vidno predvsem pri mali industriji .
Observable first and foremost in small-sized industries, agro-food industries, of which 90% are SMEs, will particularly benefit from many research activities, including targeted dissemination and technology transfer activities, in particular as regards the integration and uptake of advanced eco-efficient technologies, methodologies and processes and the development of standards.
Priloga I, del Teme, oddelek 2 – Prehrana, kmetijstvo in biotehnologija, pododdelek Dejavnosti, prvi naslov Trajnostna proizvodnja in gospodarjenje ..., alinea 1 a (novo)
Annex I, part ‘Themes’, section 2 (‘Food, Agriculture and Biotechnology’), subsection ‘Activities’, first heading ('Sustainable production and management of ...'), indent 1 a (new)
– Namen raziskav biološke raznovrstnosti in njenih molekularnih značilnosti je, da se jo zaščiti, ne pa zgolj odkrivanje novih načinov za njeno izkoriščanje.
– Investigating biodiversity and its molecular characterisation is aimed at its protection, not only at identifying new ways for its exploitation.
Zaščita in ohranjanje okolja je bistvena sestavina trajnostnega upravljanja z biološkimi viri.
Environmental protection and preservation is a key element of the sustainable management of biological resources.
Treba si je prizadevati za povezovanje s temo "Okolje".
Integration with the “Environment” theme should be sought.
Izguba raznovrstnosti zelo hitro napreduje in človeške tovarne ne morejo nadomestiti tega, kar izgubljamo.
The loss of diversity is advancing rapidly and human factories cannot replace what we are losing.
Pomembno je, da se v laboratoriju, opremljenem s sodobnimi biotehnološkimi orodji, razvije in izvaja taksonomija DNK, bioinformatika pa bi pospešila popisovanje biološke raznovrstnosti in odprla nove možnosti za ekološko raziskovanje ter spodbudila varstvo biološke raznovrstnosti.
It is important develop and implement DNA taxonomy in a laboratory equipped with modern tools of biotechnology and bioinformatics would speed up inventorying of biological diversity and open new opportunities for ecological research and promote biodiversity protection.
Priloga I, del Teme, oddelek 2 – Prehrana, kmetijstvo in biotehnologija, pododdelek Dejavnosti, prvi naslov Trajnostna proizvodnja in gospodarjenje ..., alinea 2
Annex I, part 'Themes', section 2 ('Food, Agriculture and Biotechnology'), subsection 'Activities', first heading ('Sustainable production and management of ...'), indent 2
– Povečana trajnost in konkurenčnost ob zmanjšanju okoljskih vplivov v kmetijstvu, gozdarstvu, ribištvu in ribogojstvu z razvojem novih tehnologij, opreme, nadzornih sistemov, novih rastlin in proizvodnih sistemov, izboljšanje znanstvene in tehnične osnove upravljanja ribištva ter boljše razumevanje medsebojnega delovanja različnih sistemov (kmetijstvo in gozdarstvo; ribištvo in ribogojstvo) v okviru pristopa celostnega obravnavanja ekosistemov.
- Increased sustainability and competitiveness, while decreasing environmental impacts, in agriculture, forestry, fisheries and aquaculture through the development of new technologies, equipment, monitoring systems, novel plants and production systems, the improvement of the scientific and technical basis of fisheries management, and a better understanding of the interaction between different systems (agriculture and forestry; fisheries and aquaculture) across a whole ecosystem approach.
Pri zemeljskih bioloških virih bo poseben poudarek na nizkih vložkih in organskih proizvodnih sistemih, izboljšanem upravljanju z viri, novo krmo in novimi rastlinami (pridelki in drevesa) z izboljšano sestavo, odpornostjo na stres, učinkovitostjo rabe hranil in strukturo.
For land based biological resources, special emphasis will be placed on low input and organic production systems, improved management of resources and novel feeds, and novel plants (crops and trees) with improved composition, resistance to stress, nutrient use efficiency, and architecture.
To bo podprto z raziskavami biovarnosti, soobstoja in sledljivosti novih rastlinskih sistemov in proizvodov.
This will be supported through research into biosafety, co-existence and traceability of novel plants systems and products.
Zdravje rastlin bo izboljšano s pomočjo boljšega razumevanja ekologije, biologije škodljivcev, bolezni in drugih groženj ter podpore pri nadzoru nad izbruhi bolezni in izboljšanimi orodji in tehnikami za trajnostno zatiranje škodljivcev.
Plant health will be improved through better understanding of ecology, biology of pests, diseases and other threats and support to controlling disease outbreaks and enhancing sustainable pest management tools and techniques.